Allergy Asthma Immunol Res.  2016 Mar;8(2):146-155. 10.4168/aair.2016.8.2.146.

Defining Chronic Cough: A Systematic Review of the Epidemiological Literature

• Song WJ
• Chang YS
• Faruqi S
• Kang MK
• Kim JY
• Kang MG
• Kim S
• Jo EJ
• Lee SE
• Kim MH
• Plevkova J
• Park HW
• Cho SH
• Morice AH

• KMID: 2165931
• DOI: http://doi.org/10.4168/aair.2016.8.2.146

Abstract

PURPOSE
Recent evidence suggests a global burden of chronic cough in general populations. However, the definitions vary greatly among epidemiological studies, and none have been validated for clinical relevance. We aimed to examine previous epidemiological definitions in detail and explore the operational characteristics.
METHODS
A systematic review was conducted for epidemiological surveys that reported the prevalence of chronic cough in general adult populations during the years 1980 to 2013. A literature search was performed on Pubmed and Embase without language restriction. Epidemiological definitions for chronic cough were classified according to their components, such as cutoff duration. Meta-analyses were performed for the male-to-female ratio of chronic cough prevalence to explore operational characteristics of epidemiological definitions.
RESULTS
A total of 70 studies were included in the systematic review. The most common epidemiological definition was identified as 'cough > or =3 months' duration without specification of phlegm (n=50); however, it conflicted with the cutoff duration in current clinical guidelines (cough > or =8 weeks). Meta-analyses were performed for the male-to-female ratio of chronic cough among 28 studies that reported sex-specific prevalence using the most common definition. The pooled male-to-female odds ratio was 1.26 (95% confidence interval 0.92-1.73) with significant heterogeneity (I2=96%, P<0.001), which was in contrast to clinical observations of female predominance from specialist clinics. Subgroup analyses did not reverse the ratio or reduce the heterogeneity.
CONCLUSIONS
This study identified major issues in defining chronic cough in future epidemiological studies. The conflict between epidemiological and clinical diagnostic criteria needs to be resolved. The unexpected difference in the gender predominance between the community and clinics warrants further studies. Clinical validation of the existing definition is required.

Keyword

Cough; epidemiology; definition

MeSH Terms

Adult
Cough*
Epidemiologic Studies
Epidemiology
Female
Humans
Odds Ratio
Population Characteristics
Prevalence
Specialization

Figure

• 

  Fig. 1 PRISMA for study selection.

• 

  Fig. 2 Time trends in the utilization of definitions in epidemiological studies. (A) Time trends among all articles which reported the prevalence of chronic cough (n=70). (B) Time trends among a subgroup of articles which reported the prevalence of chronic cough as the primary outcome (n=13).

• 

  Fig. 3 Forest plots for male-to-female ratio in 28 epidemiological studies using a 'cough ≥3 months' definition and quality effects model. Study name indicates the first author and publication year, and they were ordered according to the study year (the number within the parenthesis). OR, odds ratio; 95% CI, 95% confidence interval.

Reference

1. Morice AH. Epidemiology of cough. Pulm Pharmacol Ther. 2002; 15:253–259.

2. Song WJ, Chang YS, Faruqi S, Kim JY, Kang MG, Kim S, et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J. 2015; 45:1479–1481.

3. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998; 158:1657–1661.

4. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129:1S–23S.

5. Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe J, et al. The diagnosis and management of chronic cough. Eur Respir J. 2004; 24:481–492.

6. Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther. 2003; 17:1515–1520.

7. O'Hara J, Jones NS. "Post-nasal drip syndrome": most patients with purulent nasal secretions do not complain of chronic cough. Rhinology. 2006; 44:270–273.

8. McGarvey LP. Does idiopathic cough exist? Lung. 2008; 186:Suppl 1. S78–S81.

9. Chung KF. Chronic 'cough hypersensitivity syndrome': a more precise label for chronic cough. Pulm Pharmacol Ther. 2011; 24:267–271.

10. Chung KF, McGarvey L, Mazzone SB. Chronic cough as a neuropathic disorder. Lancet Respir Med. 2013; 1:414–422.

11. Morice AH, Millqvist E, Belvisi MG, Bieksiene K, Birring SS, Chung KF, et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014; 44:1132–1148.

12. Song WJ, Chang YS, Morice AH. Changing the paradigm for cough: does 'cough hypersensitivity' aid our understanding. Asia Pac Allergy. 2014; 4:3–13.

13. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6:e1000097.

14. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013; 67:974–978.

15. Morice AH, Jakes AD, Faruqi S, Birring SS, McGarvey L, Canning B, et al. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J. 2014; 44:1149–1155.

16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557–560.

17. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010; 1:97–111.

18. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006; 295:676–680.

19. Adams RJ, Appleton SL, Wilson DH, Taylor AW, Ruffin RE. Associations of physical and mental health problems with chronic cough in a representative population cohort. Cough. 2009; 5:10.

20. Amigo H, Oyarzun MG, Bustos P, Rona RJ. Respiratory consequences of light and moderate smoking in young adults in Chile. Int J Tuberc Lung Dis. 2006; 10:744–749.

21. Bakke P, Eide GE, Hanoa R, Gulsvik A. Occupational dust or gas exposure and prevalences of respiratory symptoms and asthma in a general population. Eur Respir J. 1991; 4:273–278.

22. Bende M, Millqvist E. Prevalence of chronic cough in relation to upper and lower airway symptoms; the Skövde population-based study. Front Physiol. 2012; 3:251.

23. Brown CA, Crombie IK, Smith WC, Tunstall-Pedoe H. The impact of quitting smoking on symptoms of chronic bronchitis: results of the Scottish Heart Health Study. Thorax. 1991; 46:112–116.

24. Cerveri I, Accordini S, Corsico A, Zoia MC, Carrozzi L, Cazzoletti L, et al. Chronic cough and phlegm in young adults. Eur Respir J. 2003; 22:413–417.

25. Chen RC, Lai KF, Liu CL, Luo W, Zhong NS. An epidemiologic study of cough in young college students in Guangzhou. Zhonghua Liu Xing Bing Xue Za Zhi. 2006; 27:123–126.

26. Cheng Y, Guo YL, Yeh WY. A national survey of psychosocial job stressors and their implications for health among working people in Taiwan. Int Arch Occup Environ Health. 2001; 74:495–504.

27. Chhabra P, Sharma G, Kannan AT. Prevalence of respiratory disease and associated factors in an urban area of delhi. Indian J Community Med. 2008; 33:229–232.

28. Comstock GW, Stone RW, Tonascia JA, Johnson DH. Respiratory survey findings as predictors of disability from respiratory diseases. Am Rev Respir Dis. 1981; 124:367–371.

29. Cullinan P. Persistent cough and sputum: prevalence and clinical characteristics in south east England. Respir Med. 1992; 86:143–149.

30. Davydova LI, Khodosh EM, Nikolenko EIa. Prevalence of cough as a predictor and symptom of chronic bronchitis among male population of Kharkov. Klin Med (Mosk). 1991; 69:51–54.

31. Desalu OO, Salami AK, Fawibe AE. Prevalence of cough among adults in an urban community in Nigeria. West Afr J Med. 2011; 30:337–341.

32. Duţu S, Păun G. The prevalence of respiratory symptoms, bronchial asthma and chronic bronchitis (simple and obstructive) in a representative sample of the adult rural population. Pneumoftiziologia. 1998; 47:151–160.

33. Enright PL, Kronmal RA, Higgins MW, Schenker MB, Haponik EF. Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study. Chest. 1994; 106:827–834.

34. Ford AC, Forman D, Moayyedi P, Morice AH. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax. 2006; 61:975–979.

35. Fujimura M. Frequency of persistent cough and trends in seeking medical care and treatment-results of an internet survey. Allergol Int. 2012; 61:573–581.

36. Gundersen H, Magerøy N, Moen BE, Bråtveit M. Low traffic and respiratory symptoms among smoking females: the Hordaland Health Study. Arch Environ Occup Health. 2012; 67:189–198.

37. Hamzaçebi H, Unsal M, Kayhan S, Bilgin S, Ercan S. Prevalence of asthma and respiratory symptoms by age, gender and smoking behaviour in Samsun, North Anatolia Turkey. Tuberk Toraks. 2006; 54:322–329.

38. Hazenkamp-von Arx ME, Schindler C, Ragettli MS, Künzli N, Braun-Fahrländer C, Liu LJ. Impacts of highway traffic exhaust in alpine valleys on the respiratory health in adults: a cross-sectional study. Environ Health. 2011; 10:13.

39. Hersoug LG, Husemoen LL, Sigsgaard T, Madsen F, Linneberg A. Indoor exposure to environmental cigarette smoke, but not other inhaled particulates associates with respiratory symptoms and diminished lung function in adults. Respirology. 2010; 15:993–1000.

40. Huchon GJ, Vergnenègre A, Neukirch F, Brami G, Roche N, Preux PM. Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur Respir J. 2002; 20:806–812.

41. Iversen L, Hannaford PC, Price DB, Godden DJ. Is living in a rural area good for your respiratory health? Results from a cross-sectional study in Scotland. Chest. 2005; 128:2059–2067.

42. Jaén A, Zock JP, Kogevinas M, Ferrer A, Marín A. Occupation, smoking, and chronic obstructive respiratory disorders: a cross sectional study in an industrial area of Catalonia, Spain. Environ Health. 2006; 5:2.

43. Korn RJ, Dockery DW, Speizer FE, Ware JH, Ferris BG Jr. Occupational exposures and chronic respiratory symptoms. A population-based study. Am Rev Respir Dis. 1987; 136:298–304.

44. Krzyzanowski M, Kauffmann F. The relation of respiratory symptoms and ventilatory function to moderate occupational exposure in a general population. Results from the French PAARC study of 16,000 adults. Int J Epidemiol. 1988; 17:397–406.

45. Krzyzanowski M, Wysocki M. The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study. Int J Epidemiol. 1986; 15:56–64.

46. Kumar R, Sharma M, Srivastva A, Thakur JS, Jindal SK, Parwana HK. Association of outdoor air pollution with chronic respiratory morbidity in an industrial town in northern India. Arch Environ Health. 2004; 59:471–477.

47. Lai CK, Ho SC, Lau J, Yuen YK, Ho SS, Chan CH, et al. Respiratory symptoms in elderly Chinese living in Hong Kong. Eur Respir J. 1995; 8:2055–2061.

48. Lâm HT, Rönmark E, Tu’ò’ng NV, Ekerljung L, Chúc NT, Lundbäck B. Increase in asthma and a high prevalence of bronchitis: results from a population study among adults in urban and rural Vietnam. Respir Med. 2011; 105:177–185.

49. Lebowitz MD. Multivariate analysis of smoking and other risk factors for obstructive lung diseases and related symptoms. J Chronic Dis. 1982; 35:751–758.

50. Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms, and diseases : a comparative study between northern Sweden and northern Finland: report from the FinEsS study. Chest. 2001; 119:852–861.

51. Lötvall J, Ekerljung L, Rönmark EP, Wennergren G, Lindén A, Rönmark E, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res. 2009; 10:94.

52. Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J. 1991; 4:257–266.

53. Mahesh PA, Jayaraj BS, Prabhakar AK, Chaya SK, Vijayasimha R. Prevalence of chronic cough, chronic phlegm & associated factors in Mysore, Karnataka, India. Indian J Med Res. 2011; 134:91–100.

54. Matsuda S, Nguyen AL, Jonai H, Nguyen VH, Dinh HT, Le VT, et al. Occupational exposure and chronic respiratory symptoms--a population based study in Vietnam. Ind Health. 1997; 35:271–277.

55. Mensinga TT, Schouten JP, Rijcken B, Weiss ST, Speizer FE, van der Lende R. The relationship of eosinophilia and positive skin test reactivity to respiratory symptom prevalence in a communitybased population study. J Allergy Clin Immunol. 1990; 86:99–107.

56. Milenković B, Mitić-Milić M, Rebić P, Vukcević M, Dudvarski-Ilić A, Nagorni-Obradović L, et al. Asthma and chronic bronchitis symptoms among adult population of Belgrade. Srp Arh Celok Lek. 2011; 139:149–154.

57. Mirabelli MC, London SJ, Charles LE, Pompeii LA, Wagenknecht LE. Occupation and the prevalence of respiratory health symptoms and conditions: the Atherosclerosis Risk in Communities Study. J Occup Environ Med. 2012; 54:157–165.

58. Montnémery P, Bengtsson P, Elliot A, Lindholm LH, Nyberg P, Löfdahl CG. Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group. Respir Med. 2001; 95:744–752.

59. Mossakowska M, Pawlinska-Chmara R, Broczek KM. Asthma, allergy, and respiratory symptoms in centenarians living in Poland. J Physiol Pharmacol. 2008; 59:Suppl 6. 483–489.

60. Norboo T, Yahya M, Bruce NG, Heady JA, Ball KP. Domestic pollution and respiratory illness in a Himalayan village. Int J Epidemiol. 1991; 20:749–757.

61. Nordenstedt H, Nilsson M, Johansson S, Wallander MA, Johnsen R, Hveem K, et al. The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trøndelag health survey. Chest. 2006; 129:1051–1056.

62. Nriagu J, Robins T, Gary L, Liggans G, Davila R, Supuwood K, et al. Prevalence of asthma and respiratory symptoms in south-central Durban, South Africa. Eur J Epidemiol. 1999; 15:747–755.

63. Omenaas E, Fluge O, Buist AS, Vollmer WM, Gulsvik A. Dietary vitamin C intake is inversely related to cough and wheeze in young smokers. Respir Med. 2003; 97:134–142.

64. Pallasaho P, Lundbäck B, Meren M, Kiviloog J, Loit HM, Larsson K, et al. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med. 2002; 96:759–769.

65. Peat JK, Haby M, Spijker J, Berry G, Woolcock AJ. Prevalence of asthma in adults in Busselton, Western Australia. BMJ. 1992; 305:1326–1329.

66. Purty AJ, Bazroy J, Kar M, Vasudevan K, Veliath A, Panda P. Morbidity pattern among the elderly population in the rural area of Tamil Nadu, India. Turk J Med Sci. 2006; 36:45–50.

67. Rijcken B, Schouten JP, Weiss ST, Speizer FE, van der Lende R. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. Am Rev Respir Dis. 1987; 136:62–68.

68. Samet JM, Schrag SD, Howard CA, Key CR, Pathak DR. Respiratory disease in a New Mexico population sample of Hispanic and non-Hispanic whites. Am Rev Respir Dis. 1982; 125:152–157.

69. Schenker MB, Samet JM, Speizer FE. Effect of cigarette tar content and smoking habits on respiratory symptoms in women. Am Rev Respir Dis. 1982; 125:684–690.

70. Shin C, Lee S, Abbott RD, Kim JH, Lee SY, In KH, et al. Respiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: the Korean Health and Genome Study. Chest. 2004; 126:1234–1240.

71. Skorge TD, Eagan TM, Eide GE, Gulsvik A, Bakke PS. Indoor exposures and respiratory symptoms in a Norwegian community sample. Thorax. 2005; 60:937–942.

72. Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronconeumol. 1999; 35:159–166.

73. Song WJ, Morice AH, Kim MH, Lee SE, Jo EJ, Lee SM, et al. Cough in the elderly population: relationships with multiple comorbidity. PLoS One. 2013; 8:e78081.

74. Songür N, Aydin ZD, Oztürk O, Sahin U, Khayri U, Bircan A, et al. Respiratory symptoms, pulmonary function, and reproductive history: Isparta Menopause and Health Study. J Womens Health (Larchmt). 2010; 19:1145–1154.

75. Tollerud DJ, O'Connor GT, Sparrow D, Weiss ST. Asthma, hay fever, and phlegm production associated with distinct patterns of allergy skin test reactivity, eosinophilia, and serum IgE levels. The Normative Aging Study. Am Rev Respir Dis. 1991; 144:776–781.

76. Turcić N, Zuskin E, Mustajbegović J, Smolej-Narancić N, Ivanković D. Respiratory symptoms, diseases and pulmonary ventilatory capacity in persons in the third stage of life. Lijec Vjesn. 2002; 124:247–254.

77. Venners SA, Wang B, Ni J, Jin Y, Yang J, Fang Z, et al. Indoor air pollution and respiratory health in urban and rural China. Int J Occup Environ Health. 2001; 7:173–181.

78. Viegi G, Paoletti P, Carrozzi L, Vellutini M, Diviggiano E, Di Pede C, et al. Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of air pollution. Environ Health Perspect. 1991; 94:95–99.

79. Viegi G, Paoletti P, Prediletto R, Carrozzi L, Fazzi P, Di Pede F, et al. Prevalence of respiratory symptoms in an unpolluted area of northern Italy. Eur Respir J. 1988; 1:311–318.

80. Voll-Aanerud M, Eagan TM, Plana E, Omenaas ER, Bakke PS, Svanes C, et al. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health Qual Life Outcomes. 2010; 8:107.

81. Walraven GE, Nyan OA, Van Der Sande MA, Banya WA, Ceesay SM, Milligan PJ, et al. Asthma, smoking and chronic cough in rural and urban adult communities in The Gambia. Clin Exp Allergy. 2001; 31:1679–1685.

82. Wang JH, Luo JY, Dong L, Gong J, Tong M. Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol. 2004; 10:1647–1651.

83. Wang X, Deng FR, Lv HB, Wu SW, Guo XB. Long-term effects of air pollution on the occurrence of respiratory symptoms in adults of Beijing. Beijing Da Xue Xue Bao. 2011; 43:356–359.

84. Wilson D, Takahashi K, Pan G, Chan CC, Zhang S, Feng Y, et al. Respiratory symptoms among residents of a heavy-industry province in China: prevalence and risk factors. Respir Med. 2008; 102:1536–1544.

85. Xu X, Christiani DC, Dockery DW, Wang L. Exposure-response relationships between occupational exposures and chronic respiratory illness: a community-based study. Am Rev Respir Dis. 1992; 146:413–418.

86. Zemp E, Elsasser S, Schindler C, Künzli N, Perruchoud AP, Domenighetti G, et al. The SAPALDIA Team. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). Am J Respir Crit Care Med. 1999; 159:1257–1266.

87. Zhang LX, Enarson DA, He GX, Li B, Chan-Yeung M. Occupational and environmental risk factors for respiratory symptoms in rural Beijing, China. Eur Respir J. 2002; 20:1525–1531.

88. Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet. 1997; 350:85–90.

89. Accordini S, Corsico AG, Cerveri I, Antonicelli L, Attena F, Bono R, et al. Diverging trends of chronic bronchitis and smoking habits between 1998 and 2010. Respir Res. 2013; 14:16.

90. Burr ML, Holliday RM. Why is chest disease so common in South Wales? Smoking, social class, and lung function: a survey of elderly men in two areas. J Epidemiol Community Health. 1987; 41:140–144.

91. Cetinkaya F, Gülmez I, Aydin T, Oztürk Y, Ozesmi M, Demir R. Prevalence of chronic bronchitis and associated risk factors in a rural area of Kayseri, Central Anatolia, Turkey. Monaldi Arch Chest Dis. 2000; 55:189–193.

92. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001; 164:372–377.

93. de Oca MM, Halbert RJ, Lopez MV, Perez-Padilla R, Tálamo C, Moreno D, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J. 2012; 40:28–36.

94. Desalu OO, Salami AK, Seidu OA, Olokoba AB, Fadeyi A. Factors associated with nocturnal, productive and dry cough in the young adult population of Nigeria. J Bras Pneumol. 2010; 36:325–331.

95. Duţu S, Jienescu Z, Băicoianu S. Epidemiological study of chronic bronchitis in a population sample aged 60-85 years: contributions to the study of the natural history of chronic bronchitis (author's transl). Respiration. 1980; 39:49–59.

96. Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, et al. Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis. 2004; 8:369–376.

97. Freitas FT, Yokota RT, de Castro AP, Andrade SS, Nascimento GL, de Moura NF, et al. Prevalence of respiratory symptoms in areas of the Federal District, Brazil. Rev Panam Salud Publica. 2011; 29:451–456.

98. Frostad A, Søyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med. 2006; 259:520–529.

99. Golshan M, Faghihi M, Marandi MM. Indoor women jobs and pulmonary risks in rural areas of Isfahan, Iran, 2000. Respir Med. 2002; 96:382–388.

100. Grievink L, Smit HA, Ocké MC, van 't Veer P, Kromhout D. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax. 1998; 53:166–171.

101. Jakeways N, McKeever T, Lewis SA, Weiss ST, Britton J. Relationship between FEV1 reduction and respiratory symptoms in the general population. Eur Respir J. 2003; 21:658–663.

102. Ko FW, Lai CK, Woo J, Ho SC, Ho CW, Goggins W, et al. 12-year change in prevalence of respiratory symptoms in elderly Chinese living in Hong Kong. Respir Med. 2006; 100:1598–1607.

103. Littlejohns P, Ebrahim S, Anderson R. Prevalence and diagnosis of chronic respiratory symptoms in adults. BMJ. 1989; 298:1556–1560.

104. Pertuzé J, Contreras G, Deck C, Ferretti R, Lisboa C, Cruz E, et al. Respiratory symptoms, pulmonary function and the smoking habit in urban and rural areas of Chile. Rev Med Chil. 1986; 114:993–999.

105. von Hertzen L, Reunanen A, Impivaara O, Mälkiä E, Aromaa A. Airway obstruction in relation to symptoms in chronic respiratory disease--a nationally representative population study. Respir Med. 2000; 94:356–363.

106. Wheaton AG, Ford ES, Thompson WW, Greenlund KJ, Presley-Cantrell LR, Croft JB. Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States--National Health and Nutrition Examination Survey 2007-2010. BMC Public Health. 2013; 13:854.

107. Wicht CL, Kotze TJ. The influence of smoking habits on the symptoms of diffuse obstructive pulmonary syndrome. S Afr Med J. 1981; 60:26–30.

108. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet. 1965; 1:775–779.

109. Liard R, Neukirch F. Questionnaires: a major instrument for respiratory epidemiology. Eur Respir Monogr. 2000; 15:154–166.

110. Pistelli F, Maio S. Questionnaires and lung function. ERS Monogr. 2014; 65:257–272.

111. McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, et al. Evaluation and outcome of patients with chronic nonproductive cough using a comprehensive diagnostic protocol. Thorax. 1998; 53:738–743.

112. Mello CJ, Irwin RS, Curley FJ. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med. 1996; 156:997–1003.

113. Smyrnios NA, Irwin RS, Curley FJ. Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest. 1995; 108:991–997.

114. Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest. 1998; 114:133S–181S.

115. Faruqi S, Murdoch RD, Allum F, Morice AH. On the definition of chronic cough and current treatment pathways: an international qualitative study. Cough. 2014; 10:5.

116. Dicpinigaitis PV, Rauf K. The influence of gender on cough reflex sensitivity. Chest. 1998; 113:1319–1321.

117. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Sex difference in the inhaled tartaric acid cough threshold in non-atopic healthy subjects. Thorax. 1990; 45:633–634.

118. Kastelik JA, Thompson RH, Aziz I, Ojoo JC, Redington AE, Morice AH. Sex-related differences in cough reflex sensitivity in patients with chronic cough. Am J Respir Crit Care Med. 2002; 166:961–964.

119. Kelsall A, Decalmer S, McGuinness K, Woodcock A, Smith JA. Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009; 64:393–398.

120. Rostami-Hodjegan A, Abdul-Manap R, Wright CE, Tucker GT, Morice AH. The placebo response to citric acid-induced cough: pharmacodynamics and gender differences. Pulm Pharmacol Ther. 2001; 14:315–319.

121. Jorm LR, Shepherd LC, Rogers KD, Blyth FM. Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data. BMC Health Serv Res. 2012; 12:263.

122. Everett CF, Kastelik JA, Thompson RH, Morice AH. Chronic persistent cough in the community: a questionnaire survey. Cough. 2007; 3:5.

123. Song WJ, Kim JY, Jo EJ, Lee SE, Kim MH, Yang MS, et al. Capsaicin cough sensitivity is related to the older female predominant feature in chronic cough patients. Allergy Asthma Immunol Res. 2014; 6:401–408.

124. Matsumoto H, Tabuena RP, Niimi A, Inoue H, Ito I, Yamaguchi M, et al. Cough triggers and their pathophysiology in patients with prolonged or chronic cough. Allergol Int. 2012; 61:123–132.

125. Morice AH, Faruqi S, Wright CE, Thompson R, Bland JM. Cough hypersensitivity syndrome: a distinct clinical entity. Lung. 2011; 189:73–79.